Detalhe da pesquisa
1.
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
Ann Rheum Dis
; 83(4): 421-428, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071508
2.
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries.
Rheumatology (Oxford)
; 63(3): 751-764, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314967
3.
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.
Ann Rheum Dis
; 82(6): 820-828, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813538
4.
After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries.
Ann Rheum Dis
; 82(2): 175-181, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36100351
5.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Ann Rheum Dis
; 82(10): 1286-1295, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423647
6.
IL-17A and TNF synergistically drive expression of proinflammatory mediators in synovial fibroblasts via IκBζ-dependent induction of ELF3.
Rheumatology (Oxford)
; 62(2): 872-885, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792833
7.
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
Ann Rheum Dis
; 81(10): 1358-1366, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705376
8.
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries.
Rheumatology (Oxford)
; 60(2): 820-828, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810263
9.
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration.
Ann Rheum Dis
; 77(9): 1276-1282, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29730637
10.
Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints.
Acta Orthop
; 88(3): 326-333, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28093922
11.
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study.
Ann Rheum Dis
; 75(7): 1336-42, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26374404
12.
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.
Rheumatology (Oxford)
; 55(2): 230-6, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316581
13.
The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers.
Rheumatology (Oxford)
; 54(6): 1074-1079, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25433042
14.
Activation of histamine H4 receptor inhibits TNFα/IMD-0354-induced apoptosis in human salivary NS-SV-AC cells.
Apoptosis
; 19(12): 1702-11, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25239604
15.
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies.
Joint Bone Spine
; 91(2): 105671, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042363
16.
Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis.
Cell Rep Med
; 5(4): 101503, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593810
17.
Histamine transport and metabolism are deranged in salivary glands in Sjogren's syndrome.
Rheumatology (Oxford)
; 52(9): 1599-608, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23709238
18.
Toll-like receptors in human chondrocytes and osteoarthritic cartilage.
Acta Orthop
; 84(6): 585-92, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24237425
19.
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.
Ann Rheum Dis
; 71(3): 374-7, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21972242
20.
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.
Ann Rheum Dis
; 70(9): 1575-80, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21571731